Literature DB >> 3356493

Characterization of plasma membrane shedding from murine melanoma cells.

D D Taylor1, C G Taylor, C G Jiang, P H Black.   

Abstract

Tumor cells release intact portions of their plasma membranes in the process of membrane fragment shedding. This released material has been shown to inhibit various synthetic functions of normal cells, which may play an important role in certain patho-physiological events occurring in advanced-stage cancer patients. Our studies on metastatic variants of the murine B16 melanoma, B16-F1 (low incidence of lung colonization) and B16-F10 (high incidence of lung colonization) indicate that the shed membrane fragment material is composed predominantly of vesicles, ranging in size from 20 to 100 nm in diameter. The release of membrane fragments represents a small percentage (approximately 16%) of the total shedding of plasma membrane components. Membrane fragments were shed at a higher rate from the highly "metastatic" (colonizing) B16-F10 cells than from poorly metastatic B16-F1 cells, resulting in a 2-fold greater accumulation of membrane fragment material by cultures of B16-F10 cells than by B16-F1 cultures during the 48-hr assay period. The study of various intracellu ar metabolic processes (protein and RNA synthesis, glycosylation, and generation of ATP) required for the shedding of membrane fragments indicated that the shedding event is only dependent on energy when inhibitors of the above processes are present for 2 hr. Treatment of cells with these inhibitors for 8 hr results in cessation of the shedding process, indicating both a limited pool of components to be shed and the requirement for further synthesis of the shed material. Glycoprotein components of the shed membrane fragments were analyzed by SDS-polyacrylamide gel electrophoresis. In addition to quantitative differences, 2 additional bands were present in fluorographs from SDS-PAGE gels from the B16-F10 membrane fragment material which were not present in fluorographs from B16-F1 fragments. The glycoprotein components of shed membrane fragments were shown to represent selected domains of the cell's plasma membranes, in that only certain plasma membrane glycoproteins are shed as part of membrane fragments. The glycoproteins released as non-particulate molecules into the extracellular environment failed to exhibit these quantitative and qualitative differences.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3356493     DOI: 10.1002/ijc.2910410425

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  20 in total

1.  S100 and annexin proteins identify cell membrane damage as the Achilles heel of metastatic cancer cells.

Authors:  Jyoti K Jaiswal; Jesper Nylandsted
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

Review 2.  Exosomes/microvesicles: mediators of cancer-associated immunosuppressive microenvironments.

Authors:  Douglas D Taylor; Cicek Gercel-Taylor
Journal:  Semin Immunopathol       Date:  2011-06-19       Impact factor: 9.623

3.  Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET.

Authors:  Héctor Peinado; Maša Alečković; Simon Lavotshkin; Irina Matei; Bruno Costa-Silva; Gema Moreno-Bueno; Marta Hergueta-Redondo; Caitlin Williams; Guillermo García-Santos; Cyrus Ghajar; Ayuko Nitadori-Hoshino; Caitlin Hoffman; Karen Badal; Benjamin A Garcia; Margaret K Callahan; Jianda Yuan; Vilma R Martins; Johan Skog; Rosandra N Kaplan; Mary S Brady; Jedd D Wolchok; Paul B Chapman; Yibin Kang; Jacqueline Bromberg; David Lyden
Journal:  Nat Med       Date:  2012-06       Impact factor: 53.440

4.  Microfluidic isolation and transcriptome analysis of serum microvesicles.

Authors:  Chihchen Chen; Johan Skog; Chia-Hsien Hsu; Ryan T Lessard; Leonora Balaj; Thomas Wurdinger; Bob S Carter; Xandra O Breakefield; Mehmet Toner; Daniel Irimia
Journal:  Lab Chip       Date:  2009-12-08       Impact factor: 6.799

Review 5.  Mechanisms by which docosahexaenoic acid and related fatty acids reduce colon cancer risk and inflammatory disorders of the intestine.

Authors:  Robert S Chapkin; Jeongmin Seo; David N McMurray; Joanne R Lupton
Journal:  Chem Phys Lipids       Date:  2008-03-04       Impact factor: 3.329

6.  An active form of sphingosine kinase-1 is released in the extracellular medium as component of membrane vesicles shed by two human tumor cell lines.

Authors:  Salvatrice Rigogliuso; Chiara Donati; Donata Cassarà; Simona Taverna; Monica Salamone; Paola Bruni; Maria Letizia Vittorelli
Journal:  J Oncol       Date:  2010-05-24       Impact factor: 4.375

7.  Membrane vesicles shed into the extracellular medium by human breast carcinoma cells carry tumor-associated surface antigens.

Authors:  V Dolo; E Adobati; S Canevari; M A Picone; M L Vittorelli
Journal:  Clin Exp Metastasis       Date:  1995-07       Impact factor: 5.150

Review 8.  Cancer-derived exosomic microRNAs shape the immune system within the tumor microenvironment: State of the art.

Authors:  Francesca Fanini; Muller Fabbri
Journal:  Semin Cell Dev Biol       Date:  2016-12-09       Impact factor: 7.727

Review 9.  Role of bacterial infections in extracellular vesicles release and impact on immune response.

Authors:  Nicole Spencer; Laxmi Yeruva
Journal:  Biomed J       Date:  2020-05-23       Impact factor: 4.910

10.  Exosome removal as a therapeutic adjuvant in cancer.

Authors:  Annette M Marleau; Chien-Shing Chen; James A Joyce; Richard H Tullis
Journal:  J Transl Med       Date:  2012-06-27       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.